Geptanolimab
Geptanolimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).
| Trade Name | Geptanolimab |
| Generic | Geptanolimab |
| Geptanolimab Other Names | Genolimzumab, Geptanolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Geptanolimab
